Global Drug Repurposing Market Growth (Status and Outlook) 2025-2031

October 2025 | 96 pages | ID: G4F1FB394453EN
LP Information

Abstracts

According to this study, the global Drug Repurposing market size will reach US$ 32050 million by 2031.

Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Drug Repurposing Industry Forecast” looks at past sales and reviews total world Drug Repurposing sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug Repurposing sales for 2025 through 2031. With Drug Repurposing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Repurposing industry.

This Insight Report provides a comprehensive analysis of the global Drug Repurposing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Repurposing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Repurposing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Repurposing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Repurposing.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug Repurposing market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Oncology
• CNS Diseases
• Neurodegenerative Diseases
• Others

Segmentation by Application:

• Hospitals
• Ambulatory Surgical Centers
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Astellas Pharma
• Biovista
• Novartis
• AbbVie
• Pfizer
• Allergan
• NuMedii

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drug Repurposing Market Size (2020-2031)
  2.1.2 Drug Repurposing Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Drug Repurposing by Country/Region (2020, 2024 & 2031)
2.2 Drug Repurposing Segment by Type
  2.2.1 Oncology
  2.2.2 CNS Diseases
  2.2.3 Neurodegenerative Diseases
  2.2.4 Others
2.3 Drug Repurposing Market Size by Type
  2.3.1 Drug Repurposing Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Drug Repurposing Market Size Market Share by Type (2020-2025)
2.4 Drug Repurposing Segment by Application
  2.4.1 Hospitals
  2.4.2 Ambulatory Surgical Centers
  2.4.3 Others
2.5 Drug Repurposing Market Size by Application
  2.5.1 Drug Repurposing Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Drug Repurposing Market Size Market Share by Application (2020-2025)

3 DRUG REPURPOSING MARKET SIZE BY PLAYER

3.1 Drug Repurposing Market Size Market Share by Player
  3.1.1 Global Drug Repurposing Revenue by Player (2020-2025)
  3.1.2 Global Drug Repurposing Revenue Market Share by Player (2020-2025)
3.2 Global Drug Repurposing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 DRUG REPURPOSING BY REGION

4.1 Drug Repurposing Market Size by Region (2020-2025)
4.2 Global Drug Repurposing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drug Repurposing Market Size Growth (2020-2025)
4.4 APAC Drug Repurposing Market Size Growth (2020-2025)
4.5 Europe Drug Repurposing Market Size Growth (2020-2025)
4.6 Middle East & Africa Drug Repurposing Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Drug Repurposing Market Size by Country (2020-2025)
5.2 Americas Drug Repurposing Market Size by Type (2020-2025)
5.3 Americas Drug Repurposing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Drug Repurposing Market Size by Region (2020-2025)
6.2 APAC Drug Repurposing Market Size by Type (2020-2025)
6.3 APAC Drug Repurposing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Drug Repurposing Market Size by Country (2020-2025)
7.2 Europe Drug Repurposing Market Size by Type (2020-2025)
7.3 Europe Drug Repurposing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drug Repurposing by Region (2020-2025)
8.2 Middle East & Africa Drug Repurposing Market Size by Type (2020-2025)
8.3 Middle East & Africa Drug Repurposing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL DRUG REPURPOSING MARKET FORECAST

10.1 Global Drug Repurposing Forecast by Region (2026-2031)
  10.1.1 Global Drug Repurposing Forecast by Region (2026-2031)
  10.1.2 Americas Drug Repurposing Forecast
  10.1.3 APAC Drug Repurposing Forecast
  10.1.4 Europe Drug Repurposing Forecast
  10.1.5 Middle East & Africa Drug Repurposing Forecast
10.2 Americas Drug Repurposing Forecast by Country (2026-2031)
  10.2.1 United States Market Drug Repurposing Forecast
  10.2.2 Canada Market Drug Repurposing Forecast
  10.2.3 Mexico Market Drug Repurposing Forecast
  10.2.4 Brazil Market Drug Repurposing Forecast
10.3 APAC Drug Repurposing Forecast by Region (2026-2031)
  10.3.1 China Drug Repurposing Market Forecast
  10.3.2 Japan Market Drug Repurposing Forecast
  10.3.3 Korea Market Drug Repurposing Forecast
  10.3.4 Southeast Asia Market Drug Repurposing Forecast
  10.3.5 India Market Drug Repurposing Forecast
  10.3.6 Australia Market Drug Repurposing Forecast
10.4 Europe Drug Repurposing Forecast by Country (2026-2031)
  10.4.1 Germany Market Drug Repurposing Forecast
  10.4.2 France Market Drug Repurposing Forecast
  10.4.3 UK Market Drug Repurposing Forecast
  10.4.4 Italy Market Drug Repurposing Forecast
  10.4.5 Russia Market Drug Repurposing Forecast
10.5 Middle East & Africa Drug Repurposing Forecast by Region (2026-2031)
  10.5.1 Egypt Market Drug Repurposing Forecast
  10.5.2 South Africa Market Drug Repurposing Forecast
  10.5.3 Israel Market Drug Repurposing Forecast
  10.5.4 Turkey Market Drug Repurposing Forecast
10.6 Global Drug Repurposing Forecast by Type (2026-2031)
10.7 Global Drug Repurposing Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Drug Repurposing Forecast

11 KEY PLAYERS ANALYSIS

11.1 Astellas Pharma
  11.1.1 Astellas Pharma Company Information
  11.1.2 Astellas Pharma Drug Repurposing Product Offered
  11.1.3 Astellas Pharma Drug Repurposing Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Astellas Pharma Main Business Overview
  11.1.5 Astellas Pharma Latest Developments
11.2 Biovista
  11.2.1 Biovista Company Information
  11.2.2 Biovista Drug Repurposing Product Offered
  11.2.3 Biovista Drug Repurposing Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Biovista Main Business Overview
  11.2.5 Biovista Latest Developments
11.3 Novartis
  11.3.1 Novartis Company Information
  11.3.2 Novartis Drug Repurposing Product Offered
  11.3.3 Novartis Drug Repurposing Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Novartis Main Business Overview
  11.3.5 Novartis Latest Developments
11.4 AbbVie
  11.4.1 AbbVie Company Information
  11.4.2 AbbVie Drug Repurposing Product Offered
  11.4.3 AbbVie Drug Repurposing Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 AbbVie Main Business Overview
  11.4.5 AbbVie Latest Developments
11.5 Pfizer
  11.5.1 Pfizer Company Information
  11.5.2 Pfizer Drug Repurposing Product Offered
  11.5.3 Pfizer Drug Repurposing Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Pfizer Main Business Overview
  11.5.5 Pfizer Latest Developments
11.6 Allergan
  11.6.1 Allergan Company Information
  11.6.2 Allergan Drug Repurposing Product Offered
  11.6.3 Allergan Drug Repurposing Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Allergan Main Business Overview
  11.6.5 Allergan Latest Developments
11.7 NuMedii
  11.7.1 NuMedii Company Information
  11.7.2 NuMedii Drug Repurposing Product Offered
  11.7.3 NuMedii Drug Repurposing Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 NuMedii Main Business Overview
  11.7.5 NuMedii Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Drug Repurposing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Drug Repurposing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oncology
Table 4. Major Players of CNS Diseases
Table 5. Major Players of Neurodegenerative Diseases
Table 6. Major Players of Others
Table 7. Drug Repurposing Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Drug Repurposing Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Drug Repurposing Market Size Market Share by Type (2020-2025)
Table 10. Drug Repurposing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Drug Repurposing Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Drug Repurposing Market Size Market Share by Application (2020-2025)
Table 13. Global Drug Repurposing Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Drug Repurposing Revenue Market Share by Player (2020-2025)
Table 15. Drug Repurposing Key Players Head office and Products Offered
Table 16. Drug Repurposing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Drug Repurposing Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Drug Repurposing Market Size Market Share by Region (2020-2025)
Table 21. Global Drug Repurposing Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Drug Repurposing Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Drug Repurposing Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Drug Repurposing Market Size Market Share by Country (2020-2025)
Table 25. Americas Drug Repurposing Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Drug Repurposing Market Size Market Share by Type (2020-2025)
Table 27. Americas Drug Repurposing Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Drug Repurposing Market Size Market Share by Application (2020-2025)
Table 29. APAC Drug Repurposing Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Drug Repurposing Market Size Market Share by Region (2020-2025)
Table 31. APAC Drug Repurposing Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Drug Repurposing Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Drug Repurposing Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Drug Repurposing Market Size Market Share by Country (2020-2025)
Table 35. Europe Drug Repurposing Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Drug Repurposing Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Drug Repurposing Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Drug Repurposing Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Drug Repurposing Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Drug Repurposing
Table 41. Key Market Challenges & Risks of Drug Repurposing
Table 42. Key Industry Trends of Drug Repurposing
Table 43. Global Drug Repurposing Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Drug Repurposing Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Drug Repurposing Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Drug Repurposing Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Astellas Pharma Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 48. Astellas Pharma Drug Repurposing Product Offered
Table 49. Astellas Pharma Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Astellas Pharma Main Business
Table 51. Astellas Pharma Latest Developments
Table 52. Biovista Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 53. Biovista Drug Repurposing Product Offered
Table 54. Biovista Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Biovista Main Business
Table 56. Biovista Latest Developments
Table 57. Novartis Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 58. Novartis Drug Repurposing Product Offered
Table 59. Novartis Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Novartis Main Business
Table 61. Novartis Latest Developments
Table 62. AbbVie Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 63. AbbVie Drug Repurposing Product Offered
Table 64. AbbVie Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. AbbVie Main Business
Table 66. AbbVie Latest Developments
Table 67. Pfizer Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 68. Pfizer Drug Repurposing Product Offered
Table 69. Pfizer Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Pfizer Main Business
Table 71. Pfizer Latest Developments
Table 72. Allergan Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 73. Allergan Drug Repurposing Product Offered
Table 74. Allergan Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Allergan Main Business
Table 76. Allergan Latest Developments
Table 77. NuMedii Details, Company Type, Drug Repurposing Area Served and Its Competitors
Table 78. NuMedii Drug Repurposing Product Offered
Table 79. NuMedii Drug Repurposing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. NuMedii Main Business
Table 81. NuMedii Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Drug Repurposing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Repurposing Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Drug Repurposing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Drug Repurposing Sales Market Share by Country/Region (2024)
Figure 8. Drug Repurposing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Drug Repurposing Market Size Market Share by Type in 2024
Figure 10. Drug Repurposing in Hospitals
Figure 11. Global Drug Repurposing Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Drug Repurposing in Ambulatory Surgical Centers
Figure 13. Global Drug Repurposing Market: Ambulatory Surgical Centers (2020-2025) & ($ millions)
Figure 14. Drug Repurposing in Others
Figure 15. Global Drug Repurposing Market: Others (2020-2025) & ($ millions)
Figure 16. Global Drug Repurposing Market Size Market Share by Application in 2024
Figure 17. Global Drug Repurposing Revenue Market Share by Player in 2024
Figure 18. Global Drug Repurposing Market Size Market Share by Region (2020-2025)
Figure 19. Americas Drug Repurposing Market Size 2020-2025 ($ millions)
Figure 20. APAC Drug Repurposing Market Size 2020-2025 ($ millions)
Figure 21. Europe Drug Repurposing Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Drug Repurposing Market Size 2020-2025 ($ millions)
Figure 23. Americas Drug Repurposing Value Market Share by Country in 2024
Figure 24. United States Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Drug Repurposing Market Size Market Share by Region in 2024
Figure 29. APAC Drug Repurposing Market Size Market Share by Type (2020-2025)
Figure 30. APAC Drug Repurposing Market Size Market Share by Application (2020-2025)
Figure 31. China Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 35. India Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Drug Repurposing Market Size Market Share by Country in 2024
Figure 38. Europe Drug Repurposing Market Size Market Share by Type (2020-2025)
Figure 39. Europe Drug Repurposing Market Size Market Share by Application (2020-2025)
Figure 40. Germany Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 41. France Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Drug Repurposing Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Drug Repurposing Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Drug Repurposing Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Drug Repurposing Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 54. APAC Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 55. Europe Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 57. United States Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 58. Canada Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 59. Mexico Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 60. Brazil Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 61. China Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 62. Japan Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 63. Korea Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 65. India Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 66. Australia Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 67. Germany Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 68. France Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 69. UK Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 70. Italy Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 71. Russia Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 72. Egypt Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 73. South Africa Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 74. Israel Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 75. Turkey Drug Repurposing Market Size 2026-2031 ($ millions)
Figure 76. Global Drug Repurposing Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Drug Repurposing Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Drug Repurposing Market Size 2026-2031 ($ millions)